RNA sequestration to pathological lesions of neurodegenerative diseases.
about
Selective incorporation of polyanionic molecules into hamster prions.Altered ribostasis: RNA-protein granules in degenerative disordersEukaryotic stress granules are cleared by autophagy and Cdc48/VCP functionApolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's diseaseNeuron-specific age-related decreases in dopamine receptor subtype mRNAsRNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivityEvidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus.Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid indexTranscriptional profiling of small samples in the central nervous systemFilamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Amyloid-associated nucleic acid hybridisation.Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's diseaseRNA aptamer probes as optical imaging agents for the detection of amyloid plaques.Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.Time-dependent DNA condensation induced by amyloid beta-peptide.Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor.Single cell gene expression profiling in Alzheimer's disease.Target identification for CNS diseases by transcriptional profiling.FMRP and Ataxin-2 function together in long-term olfactory habituation and neuronal translational control.Unspecific binding of cRNA probe to plaques in two mouse models for Alzheimer's disease.Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.Defects in THO/TREX-2 function cause accumulation of novel cytoplasmic mRNP granules that can be cleared by autophagy.Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activation.RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth.Activation of EP2 receptor suppresses poly(I: C) and LPS-mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs.Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes.Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanismSurface Potential Analysis of Nanoscale Biomaterials and Devices Using Kelvin Probe Force Microscopy
P2860
Q24596538-A4F8275F-786F-4E01-B9B6-44F1A94E3C8EQ24604643-B332517C-E0CA-4E55-8C2F-93358C497E8BQ24629019-DA2FC57E-A462-4042-AFC5-6EC5AE03B1A6Q26822534-1DE9E826-4594-4CA0-B7B1-543779567164Q28201402-BC035A52-17A5-403E-A63B-64E19788E9BFQ30879431-13D4813A-9ECB-4189-967B-25490D2CA972Q32028060-4A7DEE01-7DF1-4E3A-A1B8-2D3035240974Q33202255-75C9E8C2-E483-442B-8909-06211A7138B9Q33226126-EF2EEA94-FACD-453C-903D-69696CBB4DE5Q33325962-0D042C73-19D9-48EB-8950-07B1169C308BQ33703950-FD7B1668-FCFE-4F93-B4A0-16E9189FC44CQ33916513-A69160F5-437E-4FDB-ABA8-A282E6E7B926Q33984420-8C5A50BB-5A07-4F65-B4BB-716138EBBAEFQ35108312-D4A05D47-6C2A-4F12-83DE-EA4459345187Q35186435-2029FE97-B899-40AE-BF5B-60C290B4B036Q35220097-59C8A030-B605-4998-8017-2C4E6A47160EQ35565682-A71E2FE4-C413-405E-8153-DE947FE780BFQ36055556-21FA1B74-9408-4A82-BAE2-490F04353235Q36525152-4DFDE376-C998-4270-AA0A-D8BBA1D487D6Q37175279-F553F09C-6CD3-4D5B-985D-675F314DD6F9Q37475190-95577778-EDDA-4B9B-8F5F-48152D81D151Q37508885-3A4A5850-898B-47EB-8760-6523CE0B9981Q38288126-7AAF97D0-49AA-46CB-AF23-395BEAFEA01CQ38314993-77E876C8-7EC6-49D6-A1BB-1ECAFF65D6A3Q39717140-E0669DD1-673F-4939-9C3F-17DFCE717D2FQ42116332-5CD44FD5-655A-499F-AF09-47BED5675483Q42422246-667372F6-F921-477D-9CA1-5CE3BDDA883CQ47309400-47799820-43EF-4245-A7EE-82E2AA6B13E7Q47626066-E247D292-C9B0-48F0-B112-47F840C4FCE6Q54548112-434AEE2A-61B2-4365-8E8E-C67E52179C3FQ55007427-B74520AE-B20F-4B6C-AF30-3549FB4AC1CDQ56535326-C36D4A6A-616F-47B7-9063-B32759B3088AQ59127469-A25FEC33-CE4B-422A-9C93-B9DA634A257F
P2860
RNA sequestration to pathological lesions of neurodegenerative diseases.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
RNA sequestration to pathological lesions of neurodegenerative diseases.
@en
RNA sequestration to pathological lesions of neurodegenerative diseases.
@nl
type
label
RNA sequestration to pathological lesions of neurodegenerative diseases.
@en
RNA sequestration to pathological lesions of neurodegenerative diseases.
@nl
prefLabel
RNA sequestration to pathological lesions of neurodegenerative diseases.
@en
RNA sequestration to pathological lesions of neurodegenerative diseases.
@nl
P2093
P356
P1476
RNA sequestration to pathological lesions of neurodegenerative diseases
@en
P2093
J E Galvin
J Q Trojanowski
P2888
P304
P356
10.1007/S004010050923
P577
1998-11-01T00:00:00Z